Deltagen IncOver The Counter Market:DGEN
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Deltagen Inc | 40.0 | 0.0x | --- |
Photoelectron Corp | 10.0 | 0.0x | --- |
Innoveren Scientific Inc | 140.0 | 0.0x | --- |
Cyclo3pss Corp | 40.0 | 0.0x | --- |
Helius Medical Technologies Inc | 1.7M | -0.1x | --- |
Motus GI Holdings Inc | 10.0 | 0.0x | --- |
Company Information
Deltagen, Inc. is a provider of drug discovery tools and services to the biopharmaceutical industry. The Company offers a suite of programs designed to manage the efficiency of drug discovery, including access to biological models, as well as both small-molecule and secreted protein drug targets. In addition, it offers target validation data in the areas of immunology and metabolic diseases. The Company's biology approach is designed to help clear the first and major hurdle of drug target discovery: lead validation. Its DeltaBase is a searchable database of in vivo-derived mammalian gene function information and gene targets. DeltaOne from the Company provides per-gene access to the knockout mice and/or phenotypic data needed.
Contact Information
- Headquarters
- 18 Iris Lane, CarlosREDWOOD CITY, CA, United States 94070
- Phone
- 650-569-5100
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Constantine Anagnostopoulos
- Chief Executive Officer
- Larry Hill
- Chief Financial Officer
- Daniel Ratto
- Executive Vice President of Research and Development
- Geoffrey Yarranton
- Senior Vice President and New Site Director of Deltagen Research Laboratories
- Donald Karanewsky
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $40.00 |
|---|---|
Revenue (TTM) | $870.0K |
Shares Outstanding | 38.9M |
Deltagen Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.04 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | 0.0x |
Operating Margin | 17.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
